Applied Clinical Trials
Current trends in oncology trial terminations as analyzed by Citeline have revealed that sponsors are learning from the past and making gains in this troubled area of drug development.
Christine Blazynski, Ph.D.
Advertisement
Senior Vice-President, Product Development Citeline
Articles by Christine Blazynski, Ph.D.
Advertisement
Latest Updated Articles
Trends in Oncology Trial Terminations: Industry Lessons LearnedAugust 23rd 2012
- Hidden Successes of Oncology Trial Terminations
October 1st 2012
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Control Plane for Agentic Clinical Operations: Governing Autonomous Digital Actors in Regulated Trials
2
Where AI Leads in Trial Design—and Where Humans Still Need To
3
Real-World Evidence Is Moving Upstream: Is the Data Infrastructure Ready?
4
The Data Inputs That Matter Most When Pressure-Testing a Protocol's Feasibility
5